Abstract
Aspirin is now recommended for splenectomized thalassemia patients with high platelet counts. However, aspirin resistance defined by arachinodic acid (ACA) induced platelet aggregation ≥20%, has never been reported in this group of patients. In this study, twenty-four splenectomized thalassemia patients (15.7±4.1years), with platelet counts ≥800x10(9)/L, and 21 non-splenectomized severe thalassemia patients (14.3±3.2years), were enrolled. After taking aspirin (2mg/kg/day), seven patients (29.2%) displayed aspirin resistance. Serum thromboxane B2 (TXB2) levels in the aspirin responsive group decreased significantly [52.6(8.8-174.6) vs 4.0(1.6-7.3) mcg/mL, p<0.001], while no change was demonstrated in the aspirin resistant group. Having increased aspirin to 4mg/kg/day, three of the seven aspirin resistant patients responded, while one developed upper GI bleeding from esophageal varices and was withdrawn from the study. For the three remaining patients, their doses were increased to the maximum of 300mg/day, and two of the three responded. Thrombin antithrombin complex and D-dimer levels were significantly decreased after taking aspirin (2mg/kg/day), although D-dimer level was still significantly higher than that in non-splenectom...Continue Reading
References
Jun 1, 1977·Archives of Disease in Childhood·B Modell
Jul 1, 1980·The Journal of Pediatrics·A CohenE Schwartz
Sep 1, 1993·Thrombosis Research·K H GrotemeyerI W Husstedt
Jul 21, 1998·Annals of the New York Academy of Sciences·S FucharoenP Pootrakul
Dec 21, 2000·British Journal of Haematology·M D CappelliniA P Mannucci
May 29, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·R E RollerE Pilger
Sep 6, 2002·Pathophysiology of Haemostasis and Thrombosis·Iris MüllerMeinrad Gawaz
Nov 7, 2002·European Heart Journal·J W EikelboomS Yusuf
Jan 2, 2003·Nature Reviews. Drug Discovery·Deepak L Bhatt, Eric J Topol
Mar 26, 2003·Journal of the American College of Cardiology·Patricia A GumEric J Topol
Dec 3, 2003·Blood·Vichai AtichartakarnKatcharin Aryurachai
Feb 18, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·John W Eikelboom, Graeme J Hankey
Feb 28, 2004·BMJ : British Medical Journal·Graeme J Hankey, John W Eikelboom
Mar 19, 2004·Journal of the American College of Cardiology·Deepak L Bhatt
Feb 11, 2005·Journal of Thrombosis and Haemostasis : JTH·C L Campbell, S R Steinhubl
Mar 2, 2005·Annals of Internal Medicine·Simon SandersonAnn-Louise Kinmonth
Feb 21, 2006·Lancet·Graeme J Hankey, John W Eikelboom
May 6, 2006·Thrombosis Research·Jerzy DropinskiAndrew Szczeklik
May 30, 2006·Thrombosis and Haemostasis·Shen WongDavid R Lewis
Sep 28, 2006·Thrombosis and Haemostasis·Ali TaherMaria Domenica Cappellini
Sep 27, 2007·Pediatric Cardiology·Lisa C HeisteinMatthew S Lemler
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Nov 13, 2008·Pediatric Blood & Cancer·Torrey M ParkerRobert J Klaassen
Feb 23, 2010·Expert Review of Hematology·Stefano Rivella, Eliezer Rachmilewitz
Feb 11, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Sezaneh Haghpanah, Mehran Karimi
Jun 5, 2013·Haematologica·Khaled M MusallamEliezer A Rachmilewitz
Jul 6, 2014·Cardiovascular Drugs and Therapy·Roberto GrimaldiFiorenzo Gaita